On another great day for #HER2DX at St. Gallen Breast Cancer Conference, Dr. #MafaldaOliveira from #SOLTI discusses the DEFINITIVE trial, the first prospective #HER2DX trial across 44 hospitals in 7 countries.
#SGBCC2025
#breastcancer
#precisiononcology